Chan HL - Search Results

1

Diagnosis of liver fibrosis and cirrhosis using liver stiffness measurement: comparison between M and XL probe of FibroScan®.

de Lédinghen V, Wong VW, Vergniol J, Wong GL, Foucher J, Chu SH, Le Bail B, Choi PC, Chermak F, Yiu KK, Merrouche W, Chan HL. de Lédinghen V, et al. Among authors: chan hl. J Hepatol. 2012 Apr;56(4):833-9. doi: 10.1016/j.jhep.2011.10.017. Epub 2011 Dec 13. J Hepatol. 2012. PMID: 22173167

2

A cirrhotic patient with fever and abdominal pain in the presence of ascites.

Wong VW, Chan HL. Wong VW, et al. Among authors: chan hl. Hosp Med. 2003 May;64(5):310. doi: 10.12968/hosp.2003.64.5.1768. Hosp Med. 2003. PMID: 12789745 No abstract available.

3

Molecular virology in chronic hepatitis B: genotypes.

Wong GL, Chan HL. Wong GL, et al. Among authors: chan hl. Hosp Med. 2005 Jan;66(1):13-6. doi: 10.12968/hmed.2005.66.1.17529. Hosp Med. 2005. PMID: 15686160 Review.

4

Identification of chronic hepatitis B patients without significant liver fibrosis by a simple noninvasive predictive model.

Hui AY, Chan HL, Wong VW, Liew CT, Chim AM, Chan FK, Sung JJ. Hui AY, et al. Among authors: chan hl, chan fk. Am J Gastroenterol. 2005 Mar;100(3):616-23. doi: 10.1111/j.1572-0241.2005.41289.x. Am J Gastroenterol. 2005. PMID: 15743360

5

Long-term follow-up of peginterferon and lamivudine combination treatment in HBeAg-positive chronic hepatitis B.

Chan HL, Hui AY, Wong VW, Chim AM, Wong ML, Sung JJ. Chan HL, et al. Hepatology. 2005 Jun;41(6):1357-64. doi: 10.1002/hep.20695. Hepatology. 2005. PMID: 15880608 Clinical Trial.

6

A retrospective study on clinical features and prognostic factors of biopsy-proven primary biliary cirrhosis in Chinese patients.

Wong GL, Hui AY, Wong VW, Chan FK, Sung JJ, Chan HL. Wong GL, et al. Among authors: chan hl, chan fk. Am J Gastroenterol. 2005 Oct;100(10):2205-11. doi: 10.1111/j.1572-0241.2005.50007.x. Am J Gastroenterol. 2005. PMID: 16181370

7

Long-term lamivudine treatment is associated with a good maintained response in severe acute exacerbation of chronic HBeAg-negative hepatitis B.

Chan HL, Wong VW, Hui AY, Tsang SW, Chan JL, Chan HY, Wong GL, Sung JJ. Chan HL, et al. Among authors: chan hy, chan jl. Antivir Ther. 2006;11(4):465-71. Antivir Ther. 2006. PMID: 16856620 Clinical Trial.

8

Metabolic and adipokine profile of Chinese patients with nonalcoholic fatty liver disease.

Wong VW, Hui AY, Tsang SW, Chan JL, Tse AM, Chan KF, So WY, Cheng AY, Ng WF, Wong GL, Sung JJ, Chan HL. Wong VW, et al. Among authors: chan kf, chan hl, chan jl. Clin Gastroenterol Hepatol. 2006 Sep;4(9):1154-61. doi: 10.1016/j.cgh.2006.06.011. Epub 2006 Aug 14. Clin Gastroenterol Hepatol. 2006. PMID: 16904946

9

Virological response to different combination regimes of peginterferon alpha-2b and lamivudine in hepatitis B e antigen positive chronic hepatitis B.

Chan HL, Wong VW, Chim AM, Choi PC, Chan HY, Hui AY, Wong GL, Sung JJ. Chan HL, et al. Among authors: chan hy. Antivir Ther. 2007;12(5):815-23. Antivir Ther. 2007. PMID: 17713165 Clinical Trial.

10

Performance of the new MELD-Na score in predicting 3-month and 1-year mortality in Chinese patients with chronic hepatitis B.

Wong VW, Chim AM, Wong GL, Sung JJ, Chan HL. Wong VW, et al. Among authors: chan hl. Liver Transpl. 2007 Sep;13(9):1228-35. doi: 10.1002/lt.21222. Liver Transpl. 2007. PMID: 17763399 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,240 results

Search Page

Filters